IFN-β has several functions that can treat MS such as inhibiting proinflammatory cytokines IL-17, increasing anti-inflammatory agents IL-10 and attenuating leukocyte migration across the blood-brain barrier [126]. The gene discussed is IFNB1; the disease is myeloid sarcoma.